BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36190982)

  • 21. A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.
    Ziegler P; Tian Y; Bai Y; Abrahamsson S; Bäckerholm A; Reznik AS; Green A; Moore JA; Lee SE; Myerburg MM; Park HJ; Tang KW; Shair KHY
    PLoS Pathog; 2021 Apr; 17(4):e1009041. PubMed ID: 33914843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells.
    Tsang CM; Deng W; Yip YL; Zeng MS; Lo KW; Tsao SW
    Chin J Cancer; 2014 Nov; 33(11):549-55. PubMed ID: 25223910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
    Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
    Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes.
    Birdwell CE; Queen KJ; Kilgore PC; Rollyson P; Trutschl M; Cvek U; Scott RS
    J Virol; 2014 Oct; 88(19):11442-58. PubMed ID: 25056883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Tsang CM; Tsao SW
    Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.
    Tsang CM; Zhang G; Seto E; Takada K; Deng W; Yip YL; Man C; Hau PM; Chen H; Cao Y; Lo KW; Middeldorp JM; Cheung AL; Tsao SW
    Int J Cancer; 2010 Oct; 127(7):1570-83. PubMed ID: 20091869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
    Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
    J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study.
    Yip YL; Pang PS; Deng W; Tsang CM; Zeng M; Hau PM; Man C; Jin Y; Yuen AP; Tsao SW
    PLoS One; 2013; 8(10):e78395. PubMed ID: 24167620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma.
    Knox PG; Li QX; Rickinson AB; Young LS
    Virology; 1996 Jan; 215(1):40-50. PubMed ID: 8553585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Tsao SW; Wong HL; Hui JW; To KF; Hayward DS; Chui YL; Lau YL; Takada K; Huang DP
    Neoplasia; 2006 Mar; 8(3):173-80. PubMed ID: 16611410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus-induced up-regulation of TCAB1 is involved in the DNA damage response in nasopharyngeal carcinoma.
    Wang K; Ge Y; Ni C; Cui B; Du J; Zhang B; Hu X; Chen J; Xiao L; Sun C; Li Y
    Sci Rep; 2017 Jun; 7(1):3218. PubMed ID: 28607398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.
    Ali A; Ohashi M; Casco A; Djavadian R; Eichelberg M; Kenney SC; Johannsen E
    PLoS Pathog; 2022 Sep; 18(9):e1010886. PubMed ID: 36174106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation.
    Yip YL; Lin W; Deng W; Jia L; Lo KW; Busson P; Vérillaud B; Liu X; Tsang CM; Lung ML; Tsao SW
    Lab Invest; 2018 Aug; 98(8):1093-1104. PubMed ID: 29769697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.